Your browser doesn't support javascript.
loading
Exploring genetic counselors' experiences with non-paternity in clinical settings.
Cunningham, Emma; Hays, Stephen; Wainstein, Tasha; Zierhut, Heather; Virani, Alice; Tryon, Rebecca.
Afiliación
  • Cunningham E; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Hays S; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota, USA.
  • Wainstein T; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Zierhut H; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Virani A; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota, USA.
  • Tryon R; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
J Genet Couns ; 2024 Feb 07.
Article en En | MEDLINE | ID: mdl-38323428
ABSTRACT
Non-paternity (NP) is a challenging dilemma faced by genetics providers and there is little consensus on whether this finding should be disclosed. Discussions in the literature are highly theoretical, with limited research regarding how disclosure decisions are enacted in practice. We explored genetic counselors' (GCs) clinical experiences with NP to understand if, how, and why this finding is communicated. Our semi-structured interviews with genetic counselors in the United States and Canada were analyzed using reflexive thematic analysis to analyze data inductively, describe themes, and present a meaningful interpretation of the data. Eighteen participants who responded to list-serv messages were interviewed. Our framework describes five salient themes (1) GC-lab relationship the GCs awareness of laboratory processes such as quality control metrics that can uncover NP findings and the way in which a finding of NP was disclosed by the laboratory had an impact on disclosure decisions. This triggered a decision-making trajectory that involved (2) consultation, (3) ethical reasoning, and (4) practical constraints. GCs frequently consulted other professionals during decision-making. These conversations impacted disclosure decisions with some consultations carrying greater weight than others. GCs weighed moral concepts of patient autonomy, medical relevance, and preventing harm to rationalize decisions. Access to patients and documentation requirements often dictated how disclosure occurred. Finally, once a decision had been made and enacted, GCs used the experience to reconsider their approach to (5) consenting in future cases, with some GCs altering their pre-test counseling to always include a discussion of NP. Although NP scenarios are frequently unique in context, our findings demonstrate several common decision-making factors GCs harness to navigate the identification of NP through clinical genetic testing.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: J Genet Couns Asunto de la revista: GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: J Genet Couns Asunto de la revista: GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Canadá